Kundu GC[Author] - Search Results

Year	Number of Results
1991	1
1992	1
1993	1
1994	1
1996	2
1997	4
1998	2
1999	3
2000	3
2001	1
2002	2
2003	6
2004	4
2005	2
2006	5
2007	2
2008	4
2009	2
2010	7
2011	3
2012	2
2013	7
2014	7
2015	7
2016	3
2017	5
2018	6
2019	3
2020	5
2021	3

1

Breast cancer stem cells: Biology and therapeutic implications.

Butti R, Gunasekaran VP, Kumar TVS, Banerjee P, Kundu GC. Butti R, et al. Among authors: kundu gc. Int J Biochem Cell Biol. 2019 Feb;107:38-52. doi: 10.1016/j.biocel.2018.12.001. Epub 2018 Dec 5. Int J Biochem Cell Biol. 2019. PMID: 30529656 Review.

2

Non-coding RNAs as potential therapeutic targets in breast cancer.

Tomar D, Yadav AS, Kumar D, Bhadauriya G, Kundu GC. Tomar D, et al. Among authors: kundu gc. Biochim Biophys Acta Gene Regul Mech. 2020 Apr;1863(4):194378. doi: 10.1016/j.bbagrm.2019.04.005. Epub 2019 Apr 29. Biochim Biophys Acta Gene Regul Mech. 2020. PMID: 31048026 Review.

3

Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.

Butti R, Das S, Gunasekaran VP, Yadav AS, Kumar D, Kundu GC. Butti R, et al. Among authors: kundu gc. Mol Cancer. 2018 Feb 19;17(1):34. doi: 10.1186/s12943-018-0797-x. Mol Cancer. 2018. PMID: 29455658 Free PMC article. Review.

4

The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.

Yadav AS, Pandey PR, Butti R, Radharani NNV, Roy S, Bhalara SR, Gorain M, Kundu GC, Kumar D. Yadav AS, et al. Among authors: kundu gc. Front Oncol. 2018 Mar 19;8:72. doi: 10.3389/fonc.2018.00072. eCollection 2018. Front Oncol. 2018. PMID: 29616190 Free PMC article. Review.

5

Impact of semaphorin expression on prognostic characteristics in breast cancer.

Butti R, Kumar TV, Nimma R, Kundu GC. Butti R, et al. Among authors: kundu gc. Breast Cancer (Dove Med Press). 2018 May 31;10:79-88. doi: 10.2147/BCTT.S135753. eCollection 2018. Breast Cancer (Dove Med Press). 2018. PMID: 29910635 Free PMC article. Review.

6

Extracellular volatilomic alterations induced by hypoxia in breast cancer cells.

Taware R, Taunk K, Kumar TVS, Pereira JAM, Câmara JS, Nagarajaram HA, Kundu GC, Rapole S. Taware R, et al. Among authors: kundu gc. Metabolomics. 2020 Jan 24;16(2):21. doi: 10.1007/s11306-020-1635-x. Metabolomics. 2020. PMID: 31980945

7

Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near-infrared light mediated cancer therapy.

Prasad R, Jain NK, Yadav AS, Chauhan DS, Devrukhkar J, Kumawat MK, Shinde S, Gorain M, Thakor AS, Kundu GC, Conde J, Srivastava R. Prasad R, et al. Among authors: kundu gc. Commun Biol. 2020 Jun 5;3(1):284. doi: 10.1038/s42003-020-1016-z. Commun Biol. 2020. PMID: 32504032 Free PMC article.

8

Osteopontin as a therapeutic target for cancer.

Bandopadhyay M, Bulbule A, Butti R, Chakraborty G, Ghorpade P, Ghosh P, Gorain M, Kale S, Kumar D, Kumar S, Totakura KV, Roy G, Sharma P, Shetti D, Soundararajan G, Thorat D, Tomar D, Nalukurthi R, Raja R, Mishra R, Yadav AS, Kundu GC. Bandopadhyay M, et al. Among authors: kundu gc. Expert Opin Ther Targets. 2014 Aug;18(8):883-95. doi: 10.1517/14728222.2014.925447. Epub 2014 Jun 4. Expert Opin Ther Targets. 2014. PMID: 24899149 Review.

9

Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Kumar D, Gorain M, Kundu G, Kundu GC. Kumar D, et al. Among authors: kundu gc. Mol Cancer. 2017 Jan 30;16(1):7. doi: 10.1186/s12943-016-0578-3. Mol Cancer. 2017. PMID: 28137308 Free PMC article. Review.

10

Uteroglobin: a novel cytokine?

Mukherjee AB, Kundu GC, Mantile-Selvaggi G, Yuan CJ, Mandal AK, Chattopadhyay S, Zheng F, Pattabiraman N, Zhang Z. Mukherjee AB, et al. Among authors: kundu gc. Cell Mol Life Sci. 1999 May;55(5):771-87. doi: 10.1007/s000180050331. Cell Mol Life Sci. 1999. PMID: 10379362 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results